WordNet

(physiology) the process whereby nerves can retard or prevent the functioning of an organ or part; "the inhibition of the heart by the vagus nerve"
(psychology) the conscious exclusion of unacceptable thoughts or desires (同)suppression
the quality of being inhibited
not involving competition or competitiveness; "noncompetitive positions"; "noncompetitive interest in games"

PrepTutorEJDIC

禁止; 抑制; （心理学で）抑制; （化学で）（反応の）阻害, 抑制

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2013/03/22 02:38:12」(JST)

wiki en

"Non-competitive" redirects here. For other uses, see Competition.

Non-competitive inhibition is a type of enzyme inhibition where the inhibitor reduces the activity of the enzyme and binds equally well to the enzyme whether or not it has already bound the substrate.^[1]

If the inhibitor may bind to the enzyme whether or not the substrate has already been bound, but has a higher affinity for binding the enzyme in one state or the other, it is called a mixed inhibitor.^[1]

Terminology

It is important to note that, while all non-competitive inhibitors bind at allosteric sites-- i.e. any site on the enzyme other than its active site-- not all inhibitors that bind at allosteric sites are non-competitive inhibitors.^[1] ^[2] In fact, allosteric inhibitors may act as competitive, non-competitive, or uncompetitive inhibitors.^[1]

Many sources continue to conflate these two terms,^[3] ^[4] or state the definition of allosteric inhibition as the definition for non-competitive inhibition.

Mechanism

Illustration of a possible mechanism of non-competitive or mixed inhibition.

Non-competitive inhibition models a system where the inhibitor and the substrate may both be bound to the enzyme at any given time. When both the substrate and the inhibitor are bound, the enzyme-substrate-inhibitor complex cannot form product and can only be converted back to the enzyme-substrate complex or the enzyme-inhibitor complex. Non-competitive inhibition is distinguished from general mixed inhibition in that the inhibitor has an equal affinity for the enzyme and the enzyme-substrate complex.

The most common mechanism of non-competitive inhibition involves reversible binding of the inhibitor to an allosteric site, but it is possible for the inhibitor to operate via other means including direct binding to the active site. It differs from competitive inhibition in that the binding of the inhibitor does not prevent binding of substrate, and vice versa, it simply prevents product formation for a limited time.

This type of inhibition reduces the maximum rate of a chemical reaction without changing the apparent binding affinity of the catalyst for the substrate (K_m^app – see Michaelis-Menten kinetics).

Equation

In the presence of a non-competitive inhibitor, the apparent enzyme affinity is equivalent to the actual affinity. In terms of Michaelis-Menten kinetics, K_m^app = K_m. This can be seen as a consequence of Le Chatelier's Principle because the inhibitor binds to both the enzyme and the enzyme-substrate complex equally so that the equilibrium is maintained. However, since some enzyme is always inhibited from converting the substrate to product, the effective enzyme concentration is lowered.

Mathematically,

Example: noncompetitive inhibitors of CYP2C9 enzyme

Noncompetitive inhibitors of CYP2C9 enzyme include nifedipine, tranylcypromine, phenethyl isothiocyanate, and 6-hydroxyflavone. Computer docking simulation and constructed mutants substituted indicate that the noncompetitive binding site of 6-hydroxyflavone is the reported allosteric binding site of CYP2C9 enzyme.^[5]

References

^ ^a ^b ^c ^d "Types of Inhibition". http://assay.nih.gov/assay/index.php/Types_of_Inhibition. Retrieved 2 April 2012.
^ "Non Competitive Inhibitors". http://classof1.com/homework_answers/biochemical_engineering/non_competitive_inhibitors/.
^ "Noncompetitive inhibition and allosteric inhibition". Biology Online (forum). http://www.biology-online.org/biology-forum/about15032.html?hilit=Oscillates. Retrieved 2 April 2012.
^ "Noncompetitive Inhibition". http://cti.itc.virginia.edu/~cmg/Demo/noncInh.html. Retrieved 2 April 2012.
^ Si Dayong, Wang Y, Guo Y, Wang J, Zhou H, Zhou Y-H, Li Z-S, Fawcett JP (2008). Mechanism of CYP2C9 inhibition by flavones and flavonols. Drug Metabolism and Disposition. doi:10.1124/dmd.108.023416 [1]

Berg, Jeremy M.; Tymoczko, John L.; Stryer, Lubert (2000), Biochemistry (5th ed.), New York: WH Freeman & Co., ISBN 0-7167-6766-X

This biochemistry article is a stub. You can help Wikipedia by expanding it.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 筋萎縮性側索硬化症の病態修飾療法 disease modifying treatment of amyotrophic lateral sclerosis
2. 進行黒色腫に対する免疫チェックポイント分子阻害による免疫療法 immunotherapy of advanced melanoma with immune checkpoint inhibition
3. 成人の非糖尿病性慢性腎臓病患者に対する降圧療法と病状の進展 antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults
4. 薬剤の効きづらい高コレステロール血症の治療 treatment of drug resistant hypercholesterolemia
5. C型肝炎ウイルス感染に対する試験的治療 investigational therapies for hepatitis c virus infection

English Journal

The Inhibitory Effect of Metals and Other Ions on Acid Phosphatase Activity From Vigna aconitifolia Seeds.

Srivastava PK1, Anand A.
Preparative biochemistry & biotechnology.Prep Biochem Biotechnol.2015 Jan 2;45(1):33-41. doi: 10.1080/10826068.2014.887578.
Sensitivity of acid phosphatase from Vigna aconitifolia seeds to metal ions, fluoride, and phosphate was examined. All the effectors had different degree of inhibitory effect on the enzyme. Among metal ions, molybdate and ferric ion were observed to be most potent inhibitors and both exhibited mixed
PMID 24547935

Different effects of lobeline on neuronal and muscle nicotinic receptors.

Kaniakova M1, Skrenkova K2, Adamek S3, Vyskocil F2, Krusek J4.
European journal of pharmacology.Eur J Pharmacol.2014 Sep 5;738:352-9. doi: 10.1016/j.ejphar.2014.05.057. Epub 2014 Jun 12.
Lobeline is a plant alkaloid known to interact with cholinergic system. The effect of lobeline on neuronal α3β4 receptors expressed in COS cells and muscle embryonic αβγδ receptors naturally expressed in TE671 cells was studied using a patch-clamp technique. Our results show that lobeline inhi
PMID 24929055

Japanese Journal

Inhibition effects of benzylideneacetone, benzylacetone, and 4-phenyl-2-butanol on the activity of mushroom tyrosinase(ENZYMOLOGY, PROTEIN ENGINEERING, AND ENZYME TECHNOLOGY)

Journal of bioscience and bioengineering 119(3), 275-279, 2015-03
NAID 110009923566

アルキルベンゼンスルホン酸によるプロテインホスファターゼ1α活性への阻害作用の研究

北関東医学 65(1), 53-59, 2015
NAID 130005060948

緑内障点眼薬の薬物相互作用の解明と点眼薬物療法の費用最小化分析の確立

医療薬学 40(10), 543-557, 2014
NAID 130005103176

Related Pictures

★リンクテーブル★

リンク元	「非競合的拮抗」「非拮抗的阻害」「非競合的抑制」「非競合的阻害」「non-competitive inhibition」
関連記事	「inhibition」「noncompetitive」